A tumor agnostic therapeutic strategy for hexokinase 1–null/hexokinase 2–positive cancers
S Xu, HR Herschman - Cancer research, 2019 - AACR
Since Warburg's observation that most cancers exhibit elevated glycolysis, decades of
research have attempted to reduce tumor glucose utilization as a therapeutic approach …
research have attempted to reduce tumor glucose utilization as a therapeutic approach …
[HTML][HTML] HK1 from hepatic stellate cell–derived extracellular vesicles promotes progression of hepatocellular carcinoma
Q Chen, Z Zhang, Q Huang, H Chen, W Hong, T Lin… - Nature …, 2022 - nature.com
Extracellular vesicles play crucial roles in intercellular communication in the tumor
microenvironment. Here we demonstrate that in hepatic fibrosis, TGF-β stimulates the …
microenvironment. Here we demonstrate that in hepatic fibrosis, TGF-β stimulates the …
[HTML][HTML] Aiding cancer's “Sweet Tooth”: Role of hexokinases in metabolic reprogramming
Hexokinases (HKs) convert hexose sugars to hexose-6-phosphate, thus trapping them
inside cells to meet the synthetic and energetic demands. HKs participate in various …
inside cells to meet the synthetic and energetic demands. HKs participate in various …
[HTML][HTML] Chronic IL-1β-induced inflammation regulates epithelial-to-mesenchymal transition memory phenotypes via epigenetic modifications in non-small cell lung …
Chronic inflammation facilitates tumor progression. We discovered that a subset of non-
small cell lung cancer cells underwent a gradually progressing epithelial-to-mesenchymal …
small cell lung cancer cells underwent a gradually progressing epithelial-to-mesenchymal …
Degradation of hexokinase 2 blocks glycolysis and induces gsdme-dependent pyroptosis to amplify immunogenic cell death for breast cancer therapy
R Sang, R Fan, A Deng, J Gou, R Lin… - Journal of Medicinal …, 2023 - ACS Publications
Hexokinase 2 (HK2) is the principal rate-limiting enzyme in the aerobic glycolysis pathway
and determines the quantity of glucose entering glycolysis. However, the current HK2 …
and determines the quantity of glucose entering glycolysis. However, the current HK2 …
Dual inhibitions on glucose/glutamine metabolisms for nontoxic pancreatic cancer therapy
Y Xu, Z Yu, H Fu, Y Guo, P Hu, J Shi - ACS Applied Materials & …, 2022 - ACS Publications
Glucose and glutamine are two principal nutrients in mammalian cells that provide energy
and biomass for cell growth and proliferation. Especially in cancer cells, glutamine could be …
and biomass for cell growth and proliferation. Especially in cancer cells, glutamine could be …
Kaempferol impairs aerobic glycolysis against melanoma metastasis via inhibiting the mitochondrial binding of HK2 and VDAC1
X Zheng, Y Pan, G Yang, Y Liu, J Zou, H Zhao… - European journal of …, 2022 - Elsevier
Metastasis is the leading cause of death in melanoma patients. Aerobic glycolysis is a
common metabolic feature in tumor and is closely related to cell growth and metastasis …
common metabolic feature in tumor and is closely related to cell growth and metastasis …
An HK2 Antisense Oligonucleotide Induces Synthetic Lethality in HK1−HK2+ Multiple Myeloma
S Xu, T Zhou, HM Doh, KR Trinh, A Catapang, JT Lee… - Cancer research, 2019 - AACR
Although the majority of adult tissues express only hexokinase 1 (HK1) for glycolysis, most
cancers express hexokinase 2 (HK2) and many coexpress HK1 and HK2. In contrast to …
cancers express hexokinase 2 (HK2) and many coexpress HK1 and HK2. In contrast to …
A genome‐wide CRISPR activation screen reveals Hexokinase 1 as a critical factor in promoting resistance to multi‐kinase inhibitors in hepatocellular carcinoma cells
S Sofer, K Lamkiewicz, S Armoza Eilat… - The FASEB …, 2022 - Wiley Online Library
Hepatocellular carcinoma (HCC) is often diagnosed at an advanced stage and is, therefore,
treated with systemic drugs, such as tyrosine‐kinase inhibitors (TKIs). These drugs …
treated with systemic drugs, such as tyrosine‐kinase inhibitors (TKIs). These drugs …
The potent role of Src kinase-regulating glucose metabolism in cancer
W Shao, L Liu, F Zheng, Y Ma, J Zhang - Biochemical pharmacology, 2022 - Elsevier
Src kinase is a membrane-related nonreceptor tyrosine kinase that plays an essential role in
cell growth, division, migration, and survival signaling pathways. In addition, it regulates …
cell growth, division, migration, and survival signaling pathways. In addition, it regulates …